Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.20 +0.26 (+1.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Short-Term Debt repayments (2013 - 2021)

Updated

Amphastar Pharmaceuticals' Short-Term Debt repayments was $125 million in Q2 2023.

Analysis

Amphastar Pharmaceuticals (AMPH) Short-Term Debt repayments (2013 - 2021) Analysis & Trends

On a trailing twelve-month basis, Amphastar Pharmaceuticals' Short-Term Debt repayments was $125.39 million through Jun 30, 2023; for FY2021, it came in at $1.16 million.

  • In earlier years, Short-Term Debt repayments was $347,000 in FY2019.
  • The Q2 2023 figure marks the lowest quarterly Short-Term Debt repayments since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.45 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Amphastar Pharmaceuticals 1.15 Bn 6.74 Mn 93.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 387,000.00
Dec 31, 2014 6.00 Mn
Jun 30, 2014 25.00 Mn
Mar 31, 2014 15.00 Mn
Dec 31, 2013 16.00 Mn
Sep 30, 2013 15.00 Mn
API Access

Amphastar Pharmaceuticals Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=AMPH&period=max&api_key=YOUR_API_KEY